{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:04Z","timestamp":1762508704073,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clnesp.2022.02.116","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T02:44:01Z","timestamp":1645670641000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Severe acute respiratory syndrome and thyroid: A molecular point of view"],"prefix":"10.1016","volume":"48","author":[{"given":"Fatemeh","family":"Sadoughi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Maleki Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-9229","authenticated-orcid":false,"given":"Jamal","family":"Hallajzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Mansournia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clnesp.2022.02.116_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","volume":"20","author":"Baud","year":"2020","journal-title":"The Lancet Infect Dis"},{"key":"10.1016\/j.clnesp.2022.02.116_bib2","first-page":"1","article-title":"COVID-19 and the endocrine system: exploring the unexplored","author":"Pal","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"20","key":"10.1016\/j.clnesp.2022.02.116_bib3","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib4","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004311-199703540-00002","article-title":"The physiology of the endocrine system","volume":"35","author":"Lyons","year":"1997","journal-title":"Int Anesthesiol Clin"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","article-title":"Receptor recognition and cross-species infections of SARS coronavirus","volume":"100","author":"Li","year":"2013","journal-title":"Antivir Res"},{"issue":"6","key":"10.1016\/j.clnesp.2022.02.116_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"13","key":"10.1016\/j.clnesp.2022.02.116_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microb Infect"},{"issue":"5","key":"10.1016\/j.clnesp.2022.02.116_bib9","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib10","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J\u00a0Endocrinol"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00018-009-0152-x","article-title":"Not just angiotensinases: new roles for the angiotensin-converting enzymes","volume":"67","author":"Lambert","year":"2010","journal-title":"Cell Mol Life Sci : CM"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753944715597623","article-title":"ACE2 and vasoactive peptides: novel players in cardiovascular\/renal remodeling and hypertension","volume":"9","author":"Mendoza-Torres","year":"2015","journal-title":"Therapeut Adv Cardiovascular Dis"},{"issue":"6891","key":"10.1016\/j.clnesp.2022.02.116_bib14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.clnesp.2022.02.116_bib15","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.clnesp.2022.02.116_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1152\/physiolgenomics.00227.2003","article-title":"Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats","volume":"17","author":"Santos","year":"2004","journal-title":"Physiol Genom"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.clnesp.2022.02.116_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","article-title":"Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins","volume":"35","author":"Donoghue","year":"2003","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.108.122333","article-title":"Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2","volume":"53","author":"Masson","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.clnesp.2022.02.116_bib20","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis","volume":"168","author":"Oudit","year":"2006","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.clnesp.2022.02.116_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib22","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00009.2008","article-title":"Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis","volume":"295","author":"Li","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1523-1755.2002.kid559.x","article-title":"Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat","volume":"62","author":"Ferrario","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.clnesp.2022.02.116_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/01.HYP.0000126192.27644.76","article-title":"Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?","volume":"43","author":"Ye","year":"2004","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.clnesp.2022.02.116_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"Lely","year":"2004","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4149\/neo_2019_190506N405","article-title":"Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression","volume":"67","author":"Narayan","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.clnesp.2022.02.116_bib28","first-page":"1","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infectious Dis Poverty"},{"issue":"5","key":"10.1016\/j.clnesp.2022.02.116_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40618-020-01436-w","article-title":"Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis","volume":"44","author":"Rotondi","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.clnesp.2022.02.116_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12020-021-02807-w","article-title":"Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study","volume":"74","author":"Coperchini","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.clnesp.2022.02.116_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed & Pharmacotherapy\u00a0= Biomedecine & Pharmacotherapie"},{"volume":"vol. 69","year":"2020","author":"Garg","key":"10.1016\/j.clnesp.2022.02.116_bib32"},{"key":"10.1016\/j.clnesp.2022.02.116_bib33","first-page":"162","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"10.1016\/j.clnesp.2022.02.116_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019\u2014United States, February 12\u2013March 28, 2020","volume":"69","author":"Covid","year":"2020","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clnesp.2022.02.116_bib35","first-page":"1","article-title":"Thyroid disease in the time of COVID-19","author":"Dworakowska","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11154-021-09653-1","article-title":"Thyroid sequelae of COVID-19: a systematic review of reviews","volume":"22","author":"Trimboli","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2006.06.011","article-title":"Pathology of the thyroid in severe acute respiratory syndrome","volume":"38","author":"Wei","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","article-title":"Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)","volume":"63","author":"Leow","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J\u00a0Pathol: A J Pathol Soc Great Britain and Ireland"},{"key":"10.1016\/j.clnesp.2022.02.116_bib40","first-page":"E009","article-title":"A\u00a0pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua bing li xue za zhi= Chinese J Pathology"},{"issue":"2","key":"10.1016\/j.clnesp.2022.02.116_bib41","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1210\/clinem\/dgaa830","article-title":"Thyroid function before, during, and after COVID-19","volume":"106","author":"Khoo","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.clnesp.2022.02.116_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-20-0335","article-title":"Thyrotoxicosis in patients with COVID-19: the THYRCOV study","volume":"183","author":"Lania","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.clnesp.2022.02.116_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pros.24029","article-title":"Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2\/3 methylation in prostate carcinoma cells","volume":"80","author":"Wang","year":"2020","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.clnesp.2022.02.116_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40618-021-01506-7","article-title":"The cytokine storm and thyroid hormone changes in COVID-19","volume":"44","author":"Croce","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.clnesp.2022.02.116_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/thy.2020.0363","article-title":"Thyroid function analysis in 50 patients with COVID-19: a retrospective study","volume":"31","author":"Chen","year":"2021","journal-title":"Thyroid"},{"issue":"6965","key":"10.1016\/j.clnesp.2022.02.116_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457722001656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457722001656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:01:34Z","timestamp":1762498894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457722001656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":46,"alternative-id":["S2405457722001656"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.02.116","relation":{},"ISSN":["2405-4577"],"issn-type":[{"type":"print","value":"2405-4577"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute respiratory syndrome and thyroid: A molecular point of view","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.02.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}